SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000891293-21-000019
Filing Date
2021-04-20
Accepted
2021-04-20 16:39:27
Documents
5
Period of Report
2021-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A ctic_2021proxystatementdef.htm DEF 14A 778739
2 image_01a.jpg GRAPHIC 5189
3 image_11a.jpg GRAPHIC 5054
4 image_31a.jpg GRAPHIC 136188
5 image_41a.jpg GRAPHIC 139055
  Complete submission text file 0000891293-21-000019.txt   1173443
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-28386 | Film No.: 21838344
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences